Simplex Trading
RKDA icon

Simplex Trading’s Arcadia Biosciences RKDA Stock Holding History

Simplex Trading’s Portfolio RKDA Stock Details RKDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-138
Closed -$5K – 10732
2022
Q2 		$5K Buy
138
+98
+245% +$4.51K ﹤0.01% 8856
2022
Q1 		$2K Buy
+40
New +$1.91K ﹤0.01% 9922
2021
Q4 		– Sell
-48
Closed -$5K – 11292
2021
Q3 		$5K Hold
48
– – ﹤0.01% 9288
2021
Q2 		$5K Buy
48
+46
+2,300% +$5.01K ﹤0.01% 9474
2021
Q1 		$20K Sell
2
-1
-33% -$123 ﹤0.01% 7456
2020
Q4 		$27K Buy
+3
New +$366 ﹤0.01% 6756

Other funds holding RKDA

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Simplex Trading's RKDA Position: Q1 2023 in Review

Simplex Trading sold out of Arcadia Biosciences (RKDA) in Q1 2023, closing a stake of 6 shares.

Simplex Trading first reported a position in RKDA in Q1 2022 and held it in 3 quarters. The position peaked at $105K in Q1 2022. 15 funds tracked by Wall St. Rank hold RKDA as of Q1 2023.

  • Simplex Trading reported no remaining Arcadia Biosciences position as of Q1 2023 after selling out during the quarter.
  • Simplex Trading sold 6 Arcadia Biosciences shares in Q1 2023.
  • Simplex Trading first reported a position in Arcadia Biosciences in Q1 2022 and held it in 3 quarters.
  • Simplex Trading's Arcadia Biosciences position peaked at $105K in Q1 2022.
  • 15 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q1 2023.

Based on Simplex Trading's 13F filing for Q1 2023, filed 27 Apr 2023.